2009 annual financial data
Heron Therapeutics 2009 Operating margin
Direct answer
Operating margin was -812.21%.
Operating income was -10,242,000 USD and net income was -10,028,000 USD.
Operating cash flow was -10,999,000 USD.
Get free Heron Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,261,000 USD
- Operating income
- -10,242,000 USD
- Net income
- -10,028,000 USD
- Operating cash flow
- -10,999,000 USD